March 18, 2025

FDA Approves Expanded Label for ILUVIEN

The fluocinolone acetonide intravitreal implant is now indicated for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye, as well as DME.

Conexiant

March 14, 2025

Study Demonstrates Outcomes of CNV Removal for hESC-RPE

“Safe CNV removal is a prerequisite for successful hESC-RPE transplantation in patients with wet AMD,” researchers found.

Conexiant

March 11, 2025

Pregnancy Triggers Multiple Eye Changes, New Review Finds

"New glasses or refractive surgeries should be avoided until after the end of pregnancy, once visual function has stabilized or returned to the prepregnancy state," researchers recommended.

Conexiant

March 06, 2025

Private Equity Acquisitions Affect Industry Payments for Ophthalmologists

“It is unknown whether PE firms affect the financial incentives offered to physicians by other industry actors, which may change clinical decision-making," researchers note.

Conexiant

March 06, 2025

An Estimated 31 Million Americans Borrowed for Medical Bills in 2024

A new West Health-Gallup Survey survey reveals insights into medical debt across all income levels and demographics in the United States.

Conexiant

February 27, 2025

Sozinibercept PPQ Campaign Completed

The campaign consisted of the successful production of 3 consecutive commercial-scale drug product batches required to further validate Opthea’s manufacturing process in preparation for a potential biologics license application filing and commercialization of sozinibercept in wet AMD.

Ophthalmology Management

August 01, 2023

E-insights Into the Latest in Patient Care and Practice Management

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Optometric Management

September 18, 2024

Assessing the Impact of iRORA Lesions on Retina Sensitivity and Function

A new case study explores the impact of incomplete retinal pigment epithelium and outer retinal atrophy lesions on retinal sensitivity in intermediate age-related macular degeneration, shedding light on potential surrogate markers for retinal dysfunction. (Source: BMJ Open Ophthalmology)

Conexiant

September 30, 2024

Can L-DOPA Protect Against nAMD?

Patients consistently treated with L-DOPA also had lower progression rates from intermediate AMD to nAMD compared to non-treated groups.

Conexiant